Abstract
A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.
| Original language | German |
|---|---|
| Pages (from-to) | 190-196 |
| Number of pages | 7 |
| Journal | Gesundheitswesen |
| Volume | 61 |
| Issue number | 4 |
| Publication status | Published - 01-12-1999 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Public Health, Environmental and Occupational Health
Cite this
}
Vergleichende Darstellung bisheriger ökonomischer Evaluationsstudien zum Screening auf Phenylketonurie. / Ahrens, D.; Güntert, B.; Brand, A.
In: Gesundheitswesen, Vol. 61, No. 4, 01.12.1999, p. 190-196.Research output: Contribution to journal › Article
TY - JOUR
T1 - Vergleichende Darstellung bisheriger ökonomischer Evaluationsstudien zum Screening auf Phenylketonurie
AU - Ahrens, D.
AU - Güntert, B.
AU - Brand, A.
PY - 1999/12/1
Y1 - 1999/12/1
N2 - A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.
AB - A systematic review was undertaken to assess the economic value of PKU screening in the framework of newborn screening for inborn errors of metabolism. Therefore, seven international studies on this topic were connected and examined with regard to differences and similarities. The relation between costs and benefits of PKU-screening programmes goes from 1:1,2 up to 1:9,25. The differences can be explained by varying incidence of PKU (in international comparison) and particularly by methodical differences in the respective study designs. This aspect is pointed out while taking up and emphasising the necessity of standardisation in economic evaluation studies. Furthermore, future developments (chances, trends, changes) in newborn screening are discussed, based on the potential use of new technologies.
UR - http://www.scopus.com/inward/record.url?scp=0033110101&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033110101&partnerID=8YFLogxK
M3 - Article
C2 - 10408146
AN - SCOPUS:0033110101
VL - 61
SP - 190
EP - 196
JO - Gesundheitswesen
JF - Gesundheitswesen
SN - 0941-3790
IS - 4
ER -